Showing results (91-100 of 401) with videos related to
Sort By:
Pageof 41
Frontiers in Oncology|January 10, 2017
Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade GliomaCora A Ricker, Yuan Pan, David H Gutmann, et al.Neuroimage|March 27, 2007
Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivoDebasish Banerjee, Balazs Hegedus, David H Gutmann, et al.American Journal of Medical Genetics. Part A|September 5, 2003
Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcomeAllison King, Robert Listernick, Joel Charrow, et al.Annals of Neurology|March 28, 2007
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendationsRobert Listernick, Rosalie E Ferner, Grant T Liu, et al.Cancer Research|June 5, 2003
The 43000 growth-associated protein functions as a negative growth regulator in gliomaZhi-Yong Huang, YanLi Wu, Stephen P Burke, et al.Annals of Neurology|August 5, 2004
Functional significance of S6K overexpression in meningioma progressionEzequiel I Surace, Eriks Lusis, Carrie A Haipek, et al.Journal of Child Neurology|December 23, 2011
Developmental delays in children with neurofibromatosis type 1Elizabeth A Soucy, Feng Gao, David H Gutmann, et al.Neuro-Oncology|September 24, 2014
The impact of coexisting genetic mutations on murine optic glioma biologyAparna Kaul, Joseph A Toonen, Scott M Gianino, et al.Annals of Clinical and Translational Neurology|January 17, 2024
Estrogen-induced glial IL-1β mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic gliomaYunshuo Tang, Jit Chatterjee, Ngan Wagoner, et al.Bulletin of Mathematical Biology|October 24, 2018
Variability of Betweenness Centrality and Its Effect on Identifying Essential GenesChristina Durón, Yuan Pan, David H Gutmann, et al.Pageof 41